Last reviewed · How we verify

NCT05270486

Safety and Efficacy of Electromagnetic Navigation System Assisted Percutaneous Endoscopic Lumbar Decompression

Status unknown Last updated 8 March 2022
What this trial tests

trial testing Electromagnetic navigation system in Cervical Foraminal Stenosis in 20 participants. Status unknown.

Timeline
1 June 2022
Primary endpoint
31 December 2022
31 December 2023

Quick facts

Lead sponsorCentre Hospitalier Régional de la Citadelle
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment20
Start date1 June 2022
Primary completion31 December 2022
Estimated completion31 December 2023

Drugs / interventions tested

Conditions studied

Sponsor

Centre Hospitalier Régional de la Citadelle

Who can join

Adults 18 to 80, any sex, with Cervical Foraminal Stenosis or Cervical Disc Herniation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There is a shallow learning curve with TELD (transforaminal endoscopic lumbar discectomy). The aim of this study is to assess the safety and efficacy of TELD assisted by electromagnetic navigation for treating lumbar disc herniation (LDH).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Centre Hospitalier Régional de la Citadelle trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05270486.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing